App-Quantinova.ai

Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Patients with or without Identified Genetic Complement Mutations or Complement Factor H Auto-Antibodies.

Timothy H. J. Goodship - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Atypical hemolytic uremic syndrome

Eculizumab

Glycine Supplementation A Novel Therapeutic Strategy for Congenital Sideroblastic Anemia.

Jason N Berman - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sideroblastic anemia

5-aminolevulinic acid

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

Joie Davis - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute lymphoblastic leukemia

N/A

In Vitro and Ex Vivo Investigation of Aberrant and Alternative Splicing of Von Willebrand Factor.

Paula D. James - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Evithrom

Kelly M Grotzinger - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immune thrombocytopenia

Eltrombopag

Thrombocytopenia and Platelet Ultra-Structural Abnormalities Associated with RUNX1 Haploinsufficiency in Monosomy 21 Mosaicism.

Fred Pluthero - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute myelocytic leukemia

N/A

Celiac Disease: Association with Iron Deficiency in Caucasians but Not in Non-Caucasians.

Stela McLachlan - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Anemia

N/A

Platelet ERp57 Is Required for Hemostasis and Thrombosis.

Yi Wu - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Thrombophilia Screening On Venous Thromboembolism Management Practices

Jay Taylor - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Protein C

Are Children with Cancer Receiving Myelosuppressive Therapy At Risk for Transfusion-Related Iron Overload?

Rebecca Barty - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Aplastic anemia

Ferriscan

The Influence of the Duration of Storage of Red Blood Cells On Cancer Survival

Ranjeeta Mallick - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Postoperative Blood Use Following Elective Total Hip and Total Knee Arthroplasty

Yulia Lin - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastric antral vascular ectasia

Tranexamic acid

Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends

Aicha N Traore - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Hemophilia

rFVIIa

Contemporary Estimates of the Incidence of Venous Thromboembolism: A Population-Based Cohort Study

Valerie Patenaude - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Differential Expression of Markers of Apoptosis in Platelets From Children with Acute Versus Chronic Immune Thrombocytopenia

Jeanine Winkler - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immune thrombocytopenia

Phosphatidylserine

An in-Vitro Model Using Thromboelastography to Evaluate the Effects of Anticoagulants On Clot Formation in Plasma Enriched with Autologous Platelets

Ivan Stevic - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Thrombocytopenia

Fondaparinux sodium

The Economic Burden of Acute Venous Thromboembolism During One Year Following Diagnosis: A Population-Based Cohort Study

Valerie Patenaude - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

N/A

Role of the Ether-a-go-go-Related Gene 1B Isoform in Hematopoiesis

Marika Masselli - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Anemia

Cyclophosphamide

Clinical Predictors of Confirmed Venous Thromboembolism in Patients with a Suspected Recurrent Venous Thromboembolism: A Retrospective Study of the Reverse I Cohort

Melanie Tan - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

High Mortality After Venous Thromboembolism: A Population-Based Cohort Study

Valerie Patenaude - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Filters

28841 Abstracts